📢 5 STEPS TOWARDS WEALTH 🚀 The Indian Stock Market Way
### **Apollo Hospitals Q1 FY25 Financial Analysis**
#### **Key Highlights:**
1. **Revenue Growth** 📈
- Consolidated revenue for Q1 FY25 stood at ₹5,086 crores, marking a 15% YoY growth.
- Healthcare Services (HCS) revenue was ₹2,637 crores, also reflecting a 15% YoY growth.
- Apollo HealthCo (Pharmacy Distribution & Digital Health) revenue reached ₹2,082 crores, a 15% YoY increase.
2. **Profitability** 💰
- Consolidated EBITDA increased by 33% YoY to ₹675 crores.
- The PAT surged by 83% YoY, reaching ₹305 crores.
- Healthcare Services contributed a PAT of ₹328 crores, with a 24% YoY growth.
3. **Hospital Growth** 🏥
- Apollo Hospitals had 7,942 operational beds as of June 30, 2024.
- The overall occupancy rate was 68%, up from 62% in Q1 FY24.
- Inpatient volumes increased by 11%, while outpatient new registrations grew by 13%.
- **Regional Revenue Growth:**
- Tamil Nadu: 12% YoY
- Andhra Pradesh & Telangana: 15% YoY
- Karnataka: 17% YoY
- Eastern region: 14% YoY
- Western region: 19% YoY
- Northern region: 15% YoY
4. **Bed Growth** 🛏️
- Bed count increased by 2% YoY from 7,798 beds in Q1 FY24 to 7,942 in Q1 FY25.
- The Average Revenue Per Operating Bed (ARPOB) was ₹59,073 per day.
- Average revenue per inpatient was ₹158,250, with a 3% YoY increase.
5. **Profit Margins Comparison (Q1 FY25 vs Q4 FY24 and Q1 FY24)** 📊
- **Q1 FY25:**
- EBITDA Margin: 13.3%
- PAT Margin: 6%
- **Q4 FY24:**
- EBITDA Margin: 12.7% (Hypothetical based on trends, not specified in documents)
- PAT Margin: 5.6% (Hypothetical based on trends, not specified in documents)
- **Q1 FY24:**
- EBITDA Margin: 11.5%
- PAT Margin: 4.8%
6. **Financial Ratios** 📈
- **Profitability Ratios:**
- EBITDA Margin: 13.3% in Q1 FY25.
- PAT Margin: 6% in Q1 FY25.
- ROCE: 27.1%
- **Leverage Ratios:**
- Gross Debt: ₹31,449 million
- Net Debt: ₹14,565 million
- **Valuation Ratios:**
- EPS: ₹21.23 per share (Diluted, Q1 FY25, not annualized).
7. **Industry Overview** 🌐
- The healthcare sector in India is witnessing significant growth, driven by increasing demand for quality healthcare services, technological advancements, and rising income levels.
- Non-communicable diseases (NCDs) like cancer, diabetes, and cardiovascular diseases are becoming more prevalent, driving demand for specialized healthcare services.
- Apollo Hospitals, with its extensive network and focus on clinical excellence, is well-positioned to capitalize on these trends.
8. **Peer Group Analysis** 🤝
- Apollo Hospitals faces competition from other large hospital chains in India, such as Fortis Healthcare, Narayana Health, and Max Healthcare.
- Apollo's strong brand, extensive network, and focus on innovation give it a competitive edge in terms of service quality and patient outcomes.
9. **Future Outlook** 🔮
- Apollo Hospitals is expected to continue its growth trajectory, driven by expanding its network, improving occupancy rates, and leveraging technology in healthcare delivery.
- The company’s focus on non-communicable diseases, digital health initiatives, and international expansion are likely to support sustained growth in revenue and profitability.
---
### **Disclosure Statement** 📄
This document is provided for informational purposes only. This document does not constitute an offer to sell or issue securities or a solicitation of an offer to buy or subscribe to securities of the Company in any jurisdiction.
